Literature DB >> 6262378

Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.

R G Josse, T M Murray, G R Mundy, D Jez, J N Heersche.   

Abstract

Supernatant fluids from the cultures of bone marrow cells from 10 of 12 patients with multiple myeloma (MM) caused bone resorption in organ cultures of fetal rat calvaria. In four patients, the marrow cells were cultured with and without indomethacin (1 muM). The supernatant fluids from indomethacintreated marrow cultures caused significantly less bone resorption than supernatant fluids of cell cultures without indomethacin. This inhibition of release of bone resorbing factor(s) by myeloma cultures is similar to the previously observed indomethacin-induced inhibition of osteoclast-activating factor (OAF) production by activated human leukocytes. None of the MM supernatants had any effect on cyclic (c)AMP accumulation in resorbing bone in vitro. Four separate preparations of partially purified OAF obtained from phytohemagglutinin-stimulated peripheral human leukocytes were tested for their ability (a) to cause bone resorption in organ cultures of fetal rat and neonatal mouse calvaria and (b) to cause accumulation of cAMP in rat and mouse skeletal tissue in vitro. Those dilutions of OAF that caused bone resorption had no effect on accumulation of cAMP in rat or mouse calvaria incubated in vitro. In addition, no stimulation of adenylate cyclase activity in membranes prepared from fetal rat calvaria could be found. Bone cell populations isolated by sequential collagenase digestion of fetal rat calvaria also showed no cAMP response to these dilutions of OAF. Parathyroid hormone caused a clear response in all three systems. Furthermore, no cAMP response to OAF was observed in calvaria in the presence of cholera toxin (1 mug/ml) and isobutyl-methylxanthine (0.3 mM). These observations demonstrate that (a) supernatant fluids from MM marrow cultures stimulate bone resorption but do not increase cAMP accumulation in vitro; (b) indomethacin interferes with the release of bone resorbing factors by MM bone marrow cultures suggesting that this process requires prostaglandins; and (c) Sephadex G100 or G75 purified OAF does not stimulate adenylate cyclase or increase cAMP accumulation at equivalent bone resorbing concentrations in rat and mouse skeletal tissue. The resorptive action of MM culture fluids is similar to that of partially purified OAF from activated cultured leukocytes, but different from those of other bone resorbing factors, parathyroid hormone and prostaglandin E(2), which stimulate cAMP production in skeletal tissue.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262378      PMCID: PMC370715          DOI: 10.1172/jci110177

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Growth of embryonic avian and mammalian tibiae on a relatively simple chemically defined medium.

Authors:  J D BIGGERS; R B GWATKIN; S HEYNER
Journal:  Exp Cell Res       Date:  1961-10       Impact factor: 3.905

2.  A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate.

Authors:  B L Brown; J D Albano; R P Ekins; A M Sgherzi
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

3.  The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro.

Authors:  L R Chase; G D Aurbach
Journal:  J Biol Chem       Date:  1970-04-10       Impact factor: 5.157

4.  A bioassay for parathyroid hormone using whole mouse calvaria in tissue culture.

Authors:  L A Webster; D Atkins; M Peacock
Journal:  J Endocrinol       Date:  1974-09       Impact factor: 4.286

5.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

6.  Bone-resorbing activity in supernatants from lymphoid cell lines.

Authors:  G R Mundy; R A Luben; L G Raisz; J J Oppenheim; D N Buell
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

7.  The immunochemical specificity of antisera to bovine parathyroid hormone: an approach to region-specific radioimmunoassay.

Authors:  T M Murray; H T Keutmann
Journal:  J Endocrinol       Date:  1973-03       Impact factor: 4.286

8.  Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes.

Authors:  J E Horton; L G Raisz; H A Simmons; J J Oppenheim; S E Mergenhagen
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

9.  Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.

Authors:  R A Luben; G R Mundy; C L Trummel; L G Raisz
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma.

Authors:  B M Jaffe; H R Behrman; C W Parker
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

View more
  9 in total

Review 1.  The pathobiology of the osteoclast.

Authors:  T J Chambers
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

2.  Tumor products and the hypercalcemia of malignancy.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

3.  Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.

Authors:  R Bataille; D Chappard; C Marcelli; P Dessauw; P Baldet; J Sany; C Alexandre
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Skeletal effects of carcinoma of the breast and prostate.

Authors:  R C Percival
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

5.  Upper humeral cortical thickness as an indicator of osteopenia: diagnostic significance in solitary myeloma of bone.

Authors:  A Jackson; J H Scarffe
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

Review 6.  [Hypocalcemia in malignant diseases].

Authors:  E Heidbreder; K Schafferhans; A Heidland
Journal:  Klin Wochenschr       Date:  1983-08-15

7.  Hypercalcaemia and in vitro osteolysis associated with xenografts of squamous carcinomas of the tongue.

Authors:  S W Tsao; J F Burman; R L Carter
Journal:  Br J Cancer       Date:  1983-07       Impact factor: 7.640

Review 8.  Myeloma bone disease: Pathophysiology and management.

Authors:  Rebecca Silbermann; G David Roodman
Journal:  J Bone Oncol       Date:  2013-04-18       Impact factor: 4.072

9.  Further observations on mechanisms of bone destruction by squamous carcinomas of the head and neck: the role of host stroma.

Authors:  S W Tsao; J F Burman; M R Pittam; R L Carter
Journal:  Br J Cancer       Date:  1983-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.